BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24832161)

  • 21. Selected other problematic testicular and paratesticular lesions: rete testis neoplasms and pseudotumors, mesothelial lesions and secondary tumors.
    Amin MB
    Mod Pathol; 2005 Feb; 18 Suppl 2():S131-45. PubMed ID: 15502808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of galectin-3 in gonads and gonadal sex cord stromal and germ cell tumors.
    Devouassoux-Shisheboran M; Deschildre C; Mauduit C; Berger G; Mejean-Lebreton F; Bouvier R; Droz JP; FĂ©nichel P; Benahmed M
    Oncol Rep; 2006 Aug; 16(2):335-40. PubMed ID: 16820912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Practices recommendations in the applications of immunohistochemistry and molecular genetics in testicular tumors. Review article.
    Michalová K; Michal M; Hora M; Hes O; Michal M
    Cesk Patol; 2020; 56(3):153-160. PubMed ID: 33076667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Difficult differential diagnoses in testicular pathology.
    Ye H; Ulbright TM
    Arch Pathol Lab Med; 2012 Apr; 136(4):435-46. PubMed ID: 22458906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems.
    Young RH
    Mod Pathol; 2005 Feb; 18 Suppl 2():S81-98. PubMed ID: 15502809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. International Society of Urological Pathology grading and other prognostic factors for renal neoplasia.
    Delahunt B; Srigley JR; Egevad L; Montironi R;
    Eur Urol; 2014 Nov; 66(5):795-8. PubMed ID: 24890805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors.
    Zhao C; Vinh TN; McManus K; Dabbs D; Barner R; Vang R
    Am J Surg Pathol; 2009 Mar; 33(3):354-66. PubMed ID: 19033865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solid pattern yolk sac tumor: a morphologic and immunohistochemical study of 52 cases.
    Kao CS; Idrees MT; Young RH; Ulbright TM
    Am J Surg Pathol; 2012 Mar; 36(3):360-7. PubMed ID: 22261704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases.
    Zhao C; Bratthauer GL; Barner R; Vang R
    Am J Surg Pathol; 2007 Feb; 31(2):255-66. PubMed ID: 17255771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anatomic pathology of testicular tumors].
    Schill H; Arborio M; Gros P; Grippari JL
    Ann Urol (Paris); 1992; 26(2):83-9. PubMed ID: 1616307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
    Young RH
    Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibin A is a sensitive and specific marker for testicular sex cord-stromal tumors.
    Iczkowski KA; Bostwick DG; Roche PC; Cheville JC
    Mod Pathol; 1998 Aug; 11(8):774-9. PubMed ID: 9720507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SALL4 and SF-1 are sensitive and specific markers for distinguishing granulosa cell tumors from yolk sac tumors.
    Bai S; Wei S; Ziober A; Yao Y; Bing Z
    Int J Surg Pathol; 2013 Apr; 21(2):121-5. PubMed ID: 22832114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary mediastinal seminoma: a comprehensive assessment integrated with histology, immunohistochemistry, and fluorescence in situ hybridization for chromosome 12p abnormalities in 23 cases.
    Sung MT; Maclennan GT; Lopez-Beltran A; Zhang S; Montironi R; Cheng L
    Am J Surg Pathol; 2008 Jan; 32(1):146-55. PubMed ID: 18162782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The most common, clinically significant misdiagnoses in testicular tumor pathology, and how to avoid them.
    Ulbright TM
    Adv Anat Pathol; 2008 Jan; 15(1):18-27. PubMed ID: 18156809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initial management of testicular cancer: practice survey among urologists and pathologists.
    Rigaud J; Durand X; Camparo P; Avances C; Culine S; Sebe P; Flechon A; Murez T; Soulie M;
    Clin Genitourin Cancer; 2014 Aug; 12(4):292-9. PubMed ID: 24461624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic utility of SALL4 in extragonadal yolk sac tumors: an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3.
    Wang F; Liu A; Peng Y; Rakheja D; Wei L; Xue D; Allan RW; Molberg KH; Li J; Cao D
    Am J Surg Pathol; 2009 Oct; 33(10):1529-39. PubMed ID: 19574883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Many postchemotherapy sarcomatous tumors in patients with testicular germ cell tumors are sarcomatoid yolk sac tumors: a study of 33 cases.
    Howitt BE; Magers MJ; Rice KR; Cole CD; Ulbright TM
    Am J Surg Pathol; 2015 Feb; 39(2):251-9. PubMed ID: 25229769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myoid gonadal stromal tumor: a clinicopathologic study of three cases of a distinctive testicular tumor.
    Kao CS; Ulbright TM
    Am J Clin Pathol; 2014 Nov; 142(5):675-82. PubMed ID: 25319984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implications of the International Society of Urological Pathology modified Gleason grading system.
    Egevad L; Mazzucchelli R; Montironi R
    Arch Pathol Lab Med; 2012 Apr; 136(4):426-34. PubMed ID: 22458905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.